ISRCTN53706986
Completed
Not Applicable
A randomized, blinded, clinical trial assessing the efficacy of superfine merino wool base layer garments (SMWBG) in children with Atopic Dermatitis (AD) measuring SCORAD, EASI, POEM and DSA scores
Queensland Institute of Dermatology0 sites30 target enrollmentJanuary 20, 2018
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Queensland Institute of Dermatology
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
2018 results in: https://biomedres.us/fulltexts/BJSTR.MS.ID.001450.php
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Participant and/or guardian have provided informed consent
- •2\. Participant is of either sex and of any race/ethnicity and aged 6 to 25 years of age, at the time of screening
- •3\. Participant has a diagnosis of dermatitis for at least six months, proven by itchy skin located, but not limited to skin creases (front of elbows, back of knees and around eyes and neck)
- •4\. Participant's dermatitis severity should be stable with no recent hospitalisations, increased systemic steroid use or recurrent clinically significant cutaneous infections within the last 5 weeks prior to screening
- •5\. Participant or guardian must be capable of completing written questionnaires
- •6\. The participant must be capable of completing the procedural requirements of the protocol
- •7\. Optional photographic collection for research purposes
Exclusion Criteria
- •1\. Participation in any clinical trials in the last 30 days prior to screening
- •2\. Participant and or guardian(s) are unable to complete written questionnaires
- •3\. Women of childbearing potential, who are pregnant or breastfeeding or intend to become pregnant (within 2 months of completing the trial)
- •4\. Proven allergic contact dermatitis to merino wool by allergy patch testing
- •5\. Males with a clothing size greater than 2XL as determined by Investigator and/or females with clothing size greater than 18
- •6\. Participant is unable to wear garments for a minimum of 6 hours per day
- •7\. Participant has any kind of disorder that, in the opinion of the Investigator may compromise the ability of the participant or guardian to give informed consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Effect of concomitant treatment with an androgen on sexual functioning in women using an oral contraceptioISRCTN03247616Pantarhei Bioscience BV (Netherlands)81
Completed
Not Applicable
The role of omega-3 fatty acids in the management of rotator cuff tendinopathy.Rotator cuff tendinopathyMusculoskeletal DiseasesISRCTN17856844Guy's and St Thomas' NHS Foundation Trust73
Completed
Not Applicable
Post-operative low molecular weight heparin bridging therapy versus placebo bridging therapy for patients who are at high risk for arterial thromboembolismArterial thromboembolismCirculatory SystemArterial embolism and thrombosisISRCTN26119679ondon Health Sciences Centre (Canada)1,773
Completed
Not Applicable
A double blind, randomised, placebo controlled, multicentre trial of Anti-Tumour Necrotising Factor alpha (Anti-TNFa) chimeric monoclonal antibody (infliximab, Remicade®) in combination with methotrexate in patients with very early inflammatory arthritisEarly inflammatory arthritisMusculoskeletal DiseasesArthritisISRCTN21272423Medical University of Vienna (Austria)89
Completed
Not Applicable
Studying the impact of Doxycycline on fear memory in healthy individualsISRCTN66987216Psychiatric University Hospital (Psychiatrische Universitätsklinik) Zürich (PUK ZH)160